GLP-1s for Type 1 Diabetes: Are We There Yet? With Dr. Cecilia Low Wang
Diabetes Connections | Type 1 Diabetes
Release Date: 01/07/2026
Diabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures The best way to keep up with Stacey and the show is...
info_outlineDiabetes Connections | Type 1 Diabetes
Imagine getting your kids screened for T1D and agreeing to do it yourself, just to set a good example, and then your test is the one that comes back with type 1! That’s exactly what happened to Chris Dunn. She was positive for all of the autoantibodies and has since been treated with Tzield, the medication shown to delay the onset. We’re talking to her about all of that, what the treatment is actually like, how she’s doing since and what her family thinks of the whole thing. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...
info_outlineDiabetes Connections | Type 1 Diabetes
It's In the News... the top diabetes stories and headlines happening now! Top stories this week include: new islet encapsulation trial, FDA agrees to review Tzield for babies and approves the MiniMed Go, Civica releases it's version of Lantus, Eversense launches with a pump partner, scholarship for college students with diabetes and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures The best way to keep up...
info_outlineDiabetes Connections | Type 1 Diabetes
One of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications? We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I’m talking to Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years, including serving on FDA advisory committees. This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and...
info_outlineDiabetes Connections | Type 1 Diabetes
It's In the News.. a look at the top headlines and stories in the diabetes community. This week we're also making predictions for diabetes news in 2026! This week's top stories: statins and type 2, big results from Lilly's newest weight loss drug, MiniMed IPO, Tandem app update, and more! Predicitons include thouhts around: continuous ketone monitoring, noninvasive gucose moniotring, inhalable insulin for kids, GLP1 backlash, A1 slop in diabetes mom groups and more! Announcing Community Commericals! Learn how to Learn more about Please visit our Sponsors & Partners -...
info_outlineDiabetes Connections | Type 1 Diabetes
This week on Diabetes Connections, a conversation about what really matters in diabetes. We’re talking about the top stories of 2025, the hype that didn’t happen, some trends for 2026, what community can accomplish, and what LeBron James has to do with all of this. We also get personal – because I’m being interviewed by the wonderful Neil Greathouse, host of Your Best T1D life, and so much more. This episode contains a replay of This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community...
info_outlineDiabetes Connections | Type 1 Diabetes
Making the case for a better at home A1C test. Orange Biomed is developing a compact, one-drop, at-home A1C testing device they say could make frequent A1C checks easier and more accessible than ever. They’re passionate about closing the gap for people who struggle to get to clinics regularly… and the research they share is compelling: four A1C tests a year can lead to a nearly 4% reduction in A1C levels. We’ll talk about why more frequent A1C monitoring matters—even in the era of continuous glucose monitoring—how their new device works, and what early clinical trial results look...
info_outlineDiabetes Connections | Type 1 Diabetes
What if your glucose graph became a tangible piece of art? Something you could pring out and put on your water bottle or the back of your laptop. I’ve seen this in person and it makes a big impact on people. This week I’m talking to Krista Shenaman about making this type of art, her journey with type 2 – and it’s been a journey, she took a “record breaking” 28 day walk after her diagnosis.. – why she thinks its helpful to look at data in a new way and more. Full disclosure: We recorded this interview way back in 2024! Technical issues and thought it was lost,...
info_outlineDiabetes Connections | Type 1 Diabetes
It’s been a big month for announcements from Dexcom! What does that mean for you? From the commercial launch of the 15 day sensor and a smart basal feature to the announced phase out of the G6 and more, I’m talking with Jessica Castle, vice president of Global Medical Affairs at Dexcom. We’re covering all of this news and she’s answering your questions. More about More about This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to Learn more about ...
info_outlineDiabetes Connections | Type 1 Diabetes
We're looking at some major policy issues happening in Washington, and what you can really do to effect change. George Huntley is the CEO of . We’ve got a lot to cover: Medicare changes like competitive bidding that could dramatically limit access to CGMs and insulin pumps for seniors, the changing landscape around GLP 1 meds, and we talk about patient advocacy wins. I know some of you are cynical, but it can work. If you’ve ever thought your voice doesn’t matter, this conversation may change your mind. This podcast is not intended as medical advice. If you have those kinds of questions,...
info_outlineOne of the sure-thing top stories of 2026 will be GLP1s, but will we see more studies and even approval for treating type 1 with these medications?
We're talking about Ozempic, Mounjaro and the next versions like Retatrutide - that are just around the corner. I’m talking to Dr. Cecelia Lo Wong, a diabetologist at the University of Colorado whose been on the front lines of this conversation for years, including serving on FDA advisory committees.
This is a wide ranging interview - we also talk about the growing needs of older adults with type 1 diabetes, how kidney and cardiovascular risk guidelines are evolving, and why managing diabetes in the hospital can still be such a challenge.
This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
This week's Community Commercial is from Lisa Katzenberger, the author of "It Belongs to the World," a children's book version of the story of Frederick Banting and the discovery of insulin. Learn more about this book here
Announcing Community Commericals! Learn how to get your message on the show here.
Learn more about studies and research at Thrivable here
Please visit our Sponsors & Partners - they help make the show possible!
Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)
All about VIVI Cap to protect your insulin from extreme temperatures
The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
Sign up for our newsletter here
Here's where to find us:
Facebook (Group)
Facebook (Page)
Instagram
Check out Stacey's books!
Learn more about everything at our home page www.diabetes-connections.com